Don't have Telegram yet? Try it now!
https://magazine.pharmamkt.net/2019/04/26/celgene-corporation-and-acceleron-pharma-announce-submission-of-luspatercept-marketing-authorization-application-to-the-european-medicines-agency-ema-for-mds-and-beta-thalassemia/
Celgene Corporation and Acceleron Pharma Announce Submission of Luspatercept Marketing Authorization Application to the European Medicines Agency (EMA) for MDS and Beta-Thalassemia